Metropolis Healthcare Limited

NSEI:METROPOLIS Stock Report

Market Cap: ₹103.6b

Metropolis Healthcare Valuation

Is METROPOLIS undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of METROPOLIS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: METROPOLIS (₹2015.75) is trading above our estimate of fair value (₹1137.91)

Significantly Below Fair Value: METROPOLIS is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for METROPOLIS?

Key metric: As METROPOLIS is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for METROPOLIS. This is calculated by dividing METROPOLIS's market cap by their current earnings.
What is METROPOLIS's PE Ratio?
PE Ratio69.8x
Earnings₹1.48b
Market Cap₹103.60b

Price to Earnings Ratio vs Peers

How does METROPOLIS's PE Ratio compare to its peers?

The above table shows the PE ratio for METROPOLIS vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average64.1x
VIJAYA Vijaya Diagnostic Centre
88.9x25.4%₹109.7b
539871 Thyrocare Technologies
61.2x26.9%₹51.1b
LALPATHLAB Dr. Lal PathLabs
62.8x13.6%₹253.4b
KRSNAA Krsnaa Diagnostics
43.6x35.5%₹30.2b
METROPOLIS Metropolis Healthcare
69.8x23.8%₹103.6b

Price-To-Earnings vs Peers: METROPOLIS is expensive based on its Price-To-Earnings Ratio (69.8x) compared to the peer average (64.1x).

Price to Earnings Ratio vs Industry

How does METROPOLIS's PE Ratio compare vs other companies in the IN Healthcare Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
523696 Fortis Malar Hospitals
2.1xn/aUS$11.88m
542918 Gian Life Care
4.8xn/aUS$2.32m
No more companies available in this PE range
METROPOLIS 69.8xIndustry Avg. 42.6xNo. of Companies6PE020406080100+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: METROPOLIS is expensive based on its Price-To-Earnings Ratio (69.8x) compared to the Indian Healthcare industry average (42.6x).

Price to Earnings Ratio vs Fair Ratio

What is METROPOLIS's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

METROPOLIS PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio69.8x
Fair PE Ratio56.9x

Price-To-Earnings vs Fair Ratio: METROPOLIS is expensive based on its Price-To-Earnings Ratio (69.8x) compared to the estimated Fair Price-To-Earnings Ratio (56.9x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst METROPOLIS forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₹2,015.75
₹2,152.41
+6.8%
13.5%₹2,650.00₹1,691.00n/a17
Nov ’25₹2,147.20
₹2,085.53
-2.9%
13.8%₹2,490.00₹1,691.00n/a17
Oct ’25₹2,251.05
₹2,065.24
-8.3%
13.4%₹2,490.00₹1,691.00n/a17
Sep ’25₹2,139.80
₹2,065.24
-3.5%
13.4%₹2,490.00₹1,691.00n/a17
Aug ’25₹2,085.05
₹1,932.82
-7.3%
13.1%₹2,300.00₹1,486.00n/a17
Jul ’25₹2,054.65
₹1,921.13
-6.5%
13.3%₹2,300.00₹1,486.00n/a16
Jun ’25₹1,906.65
₹1,894.56
-0.6%
15.5%₹2,300.00₹1,293.00n/a16
May ’25₹1,817.75
₹1,701.60
-6.4%
12.2%₹1,973.00₹1,341.00n/a15
Apr ’25₹1,736.15
₹1,668.69
-3.9%
12.2%₹1,969.00₹1,341.00n/a13
Mar ’25₹1,713.05
₹1,661.00
-3.0%
12.5%₹1,969.00₹1,341.00n/a13
Feb ’25₹1,631.25
₹1,600.69
-1.9%
12.2%₹1,865.00₹1,298.00n/a13
Jan ’25₹1,674.55
₹1,563.23
-6.6%
14.0%₹1,893.00₹1,230.00n/a13
Dec ’24₹1,688.10
₹1,563.23
-7.4%
14.0%₹1,893.00₹1,230.00n/a13
Nov ’24₹1,416.75
₹1,422.83
+0.4%
10.9%₹1,610.00₹1,087.00₹2,147.2012
Oct ’24₹1,459.80
₹1,410.33
-3.4%
11.5%₹1,650.00₹1,087.00₹2,251.0512
Sep ’24₹1,362.90
₹1,398.00
+2.6%
11.6%₹1,650.00₹1,087.00₹2,139.8013
Aug ’24₹1,381.55
₹1,381.31
-0.02%
12.9%₹1,670.00₹1,027.00₹2,085.0513
Jul ’24₹1,493.10
₹1,372.08
-8.1%
12.1%₹1,670.00₹1,027.00₹2,054.6513
Jun ’24₹1,307.15
₹1,370.50
+4.8%
11.7%₹1,670.00₹1,027.00₹1,906.6514
May ’24₹1,251.50
₹1,511.00
+20.7%
15.2%₹1,933.00₹1,250.00₹1,817.7513
Apr ’24₹1,248.30
₹1,528.85
+22.5%
14.4%₹1,933.00₹1,250.00₹1,736.1513
Mar ’24₹1,329.35
₹1,538.08
+15.7%
15.1%₹1,933.00₹1,250.00₹1,713.0513
Feb ’24₹1,306.70
₹1,652.29
+26.4%
14.2%₹1,978.00₹1,250.00₹1,631.2514
Jan ’24₹1,327.50
₹1,667.38
+25.6%
14.6%₹2,052.00₹1,250.00₹1,674.5513
Dec ’23₹1,476.55
₹1,667.38
+12.9%
14.6%₹2,052.00₹1,250.00₹1,688.1013
Nov ’23₹1,765.25
₹1,677.31
-5.0%
16.0%₹2,134.00₹1,165.00₹1,416.7513

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Medico Intercontinental

₹557.2m

Trades in pharmaceutical products.

539938

₹61.29

7D

33.1%

1Y

-27.8%

Dr Lalchandani Labs

₹81.2m

Provides diagnostic and related healthcare tests and services in India.

541299

₹18.73

7D

4.1%

1Y

-46.5%

N G Industries

₹566.9m

Provides various healthcare services in India.

530897

₹168.05

7D

0.2%

1Y

2.7%